Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more
Market Cap & Net Worth: Darya-Varia Laboratoria Tbk (DVLA)
Darya-Varia Laboratoria Tbk (JK:DVLA) has a market capitalization of $110.84 Million (Rp1.80 Trillion) as of March 18, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #29129 globally and #474 in its home market, demonstrating a -0.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Darya-Varia Laboratoria Tbk's stock price Rp1610.00 by its total outstanding shares 1120000000 (1.12 Billion).
Darya-Varia Laboratoria Tbk Market Cap History: 2015 to 2026
Darya-Varia Laboratoria Tbk's market capitalization history from 2015 to 2026. Data shows growth from $57.45 Million to $110.84 Million (5.73% CAGR).
Index Memberships
Darya-Varia Laboratoria Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$148.31 Billion | 0.01% | #442 of 864 |
Weight: Darya-Varia Laboratoria Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Darya-Varia Laboratoria Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Darya-Varia Laboratoria Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Darya-Varia Laboratoria Tbk's market cap is 0.00 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $57.45 Million | $1.31 Trillion | $107.89 Billion | 0.00x | 0.00x |
| 2016 | $79.44 Million | $1.45 Trillion | $152.08 Billion | 0.00x | 0.00x |
| 2017 | $93.13 Million | $1.58 Trillion | $162.25 Billion | 0.00x | 0.00x |
| 2018 | $97.47 Million | $1.70 Trillion | $200.65 Billion | 0.00x | 0.00x |
| 2019 | $118.74 Million | $1.81 Trillion | $221.78 Billion | 0.00x | 0.00x |
| 2020 | $133.67 Million | $1.83 Trillion | $162.07 Billion | 0.00x | 0.00x |
| 2021 | $158.89 Million | $1.90 Trillion | $146.51 Billion | 0.00x | 0.00x |
| 2022 | $143.26 Million | $1.92 Trillion | $149.38 Billion | 0.00x | 0.00x |
| 2023 | $107.42 Million | $1.89 Trillion | $146.34 Billion | 0.00x | 0.00x |
| 2024 | $110.15 Million | $2.09 Trillion | $156.15 Billion | 0.00x | 0.00x |
Competitor Companies of DVLA by Market Capitalization
Companies near Darya-Varia Laboratoria Tbk in the global market cap rankings as of March 18, 2026.
Key companies related to Darya-Varia Laboratoria Tbk by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Darya-Varia Laboratoria Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Darya-Varia Laboratoria Tbk's market cap moved from $57.45 Million to $ 110.84 Million, with a yearly change of 5.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp110.84 Million | -2.42% |
| 2025 | Rp113.59 Million | +3.12% |
| 2024 | Rp110.15 Million | +2.54% |
| 2023 | Rp107.42 Million | -25.02% |
| 2022 | Rp143.26 Million | -9.84% |
| 2021 | Rp158.89 Million | +18.87% |
| 2020 | Rp133.67 Million | +12.57% |
| 2019 | Rp118.74 Million | +21.82% |
| 2018 | Rp97.47 Million | +4.66% |
| 2017 | Rp93.13 Million | +17.24% |
| 2016 | Rp79.44 Million | +38.28% |
| 2015 | Rp57.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Darya-Varia Laboratoria Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $110.84 Million USD |
| MoneyControl | $110.84 Million USD |
| MarketWatch | $110.84 Million USD |
| marketcap.company | $110.84 Million USD |
| Reuters | $110.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.